Skip to content

An Innovative Virtually Supervised Exercise for Dialysis Patients

An Innovative Virtually Supervised Exercise for Dialysis Patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03076528
Enrollment
100
Registered
2017-03-10
Start date
2016-11-06
Completion date
2019-02-06
Last updated
2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Failure, Diabetes, Hemodialysis Complication

Keywords

exercise, exergame, hemodialysis, balance

Brief summary

Among patients with diabetes 35% suffer from chronic renal disease and may require dialysis or kidney replacement over time. Furthermore, in diabetics with end stage renal disease (ESRD) that require dialysis, the risk of foot complications and amputation is even more common, expensive, and devastating. Interestingly, even though incidence of foot ulcers in patients with dialysis has been reported to be same as with patients with history of foot ulcers; dialysis patients have significantly higher rate of foot amputation. The goal of this research is to incorporate an innovative virtually supervised non-weight bearing exercise in patients undergoing dialysis to reduce risk of fall and foot ulceration by enhancing lower extremity blood flow, joint perception and joint mobility. Diabetic patients on hemodialysis at Hamad Medical Company will be recruited and will be randomized to either intervention (IG) or control (CG) group and followed for 6 months. The intervention group will take part in a 4-week non-weight bearing exercise program twice per week at the hemodialysis clinic under the supervision of a qualified research staff member. This intervention includes interactive game-based exercises including repetitive ankle and foot movements. Wearable sensors will provide real-time visual/auditory feedback from foot and ankle position and allowed perception of motor-errors during each motor-action. The control group will be instructed to complete a supervised foot and ankle exercise without using sensor technology. Changes in balance, gait, and physical activity, incidence of foot problems will be compared pre- and post-intervention. In addition, the incident of falls, foot ulcers, and limb amputation up to 6 months post intervention will be documented. Investigators hypothesize that patients receiving sensor-based exercises will benefit more compared to group receiving conventional non-technology training in terms of improving functional performance and reducing incidence of foot problems, falls, and limb amputation.

Interventions

This intervention includes interactive game-based lower extremity training including repetitive ankle movements in multiple directions. Wearable sensors will provide real-time feedback from foot and ankle position and allow perception of motor-errors during each motor-action

OTHERNon-technology foot and ankle exercise program

Subjects are asked to perform non-technology based foot and ankle exercises, which include plantar flexion and extension.

Sponsors

Hamad Medical Corporation
CollaboratorINDUSTRY
Qatar National Research Foundation (QNRF), Award # NPRP 7-1595-3-405
CollaboratorUNKNOWN
Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults of 50 years or older, who are undergoing hemodialysis process * Patients in diabetes * Ability to provide consent

Exclusion criteria

* Non-ambulatory patients (unable to walk independently a distance of 20m with or without existence) * Active foot ulcer * Major foot amputation * Charcot neuroarthropathy * Major hearing/vision impaired * Any patient with changes in psychotropic or sleep medications in the last 6 weeks * Patients concurrently participating in another exercise training * Patients with any clinically significant medical or psychiatric condition, or laboratory abnormality

Design outcomes

Primary

MeasureTime frameDescription
Gait Speed change from Baseline to 4 weeksBaseline and 4 weekswalking ability is quantified by gait speed
Balance change from Baseline to 4 weeks quantified by body swayBaseline and 4 weeksBalance is quantified by body sway

Secondary

MeasureTime frameDescription
Fear of Falling change from Baseline to 4 weeks using Fall Efficacy Scale International (FES-I) questionnaireBaseline and 4 weeksMeasuring fear of falling using Fall Efficacy Scale International (FES-I) questionnaire
Depression change from Baseline to 4 weeks using Center of Epidemiologic Depression Scale (CES-D) questionnaireBaseline to 4 weeksMeasuring depression using Center of Epidemiologic Depression Scale (CES-D) questionnaire
Change of Incident of fallsBaseline and 6 months
Change of Incidents of foot problemsBaseline and 6 months

Countries

Qatar

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026